Peptide Half-Life Explained: What It Means for Dosing Timing

Understand peptide half-life, steady-state accumulation, and how dosing intervals relate to compound clearance. Includes a reference table for common peptides.

What Half-Life Means for Peptides

Half-life is the time it takes for the concentration of a compound in the body to fall by half. For peptides, this determines how long a single dose remains active and when the next dose should be timed.

A peptide with a 30-minute half-life drops to half its peak concentration 30 minutes after injection, to 25% at 60 minutes, and so on. This exponential decay is why dosing intervals matter for maintaining consistent coverage.

Why Half-Life Varies Between Peptides

Different compounds have different elimination rates based on:

• Molecular structure — Longer amino acid chains are often broken down more slowly
• Modification type — PEGylated or acylated peptides (such as semaglutide) have significantly extended half-lives
• Route of administration — Subcutaneous injection releases the compound more slowly than intravenous delivery
• Individual metabolism — Age, organ function, and body composition all affect clearance rate

Common Peptide Half-Lives at a Glance

These are educational reference ranges. Actual pharmacokinetics vary by individual and preparation.

Steady State: What It Means in Practice

When dosing at regular intervals, compound levels build toward a steady state — a plateau where the amount entering the system roughly equals the amount leaving. Reaching steady state typically takes 4–5 half-lives.

For a peptide with a 30-minute half-life, steady state is reached in roughly 2–3 hours. For a weekly peptide like semaglutide with a 7-day half-life, steady state takes 4–5 weeks.

This matters when evaluating whether a protocol is "working" — it may take weeks for long-acting compounds to reach consistent systemic levels.

Dosing Timing Strategies

Pulse dosing — Used for short half-life peptides. Multiple small doses throughout the day maintain more consistent coverage. Common for growth hormone secretagogues like ipamorelin.

Depot dosing — Applies to long-acting modified peptides. A single weekly injection provides sustained coverage across the entire interval.

Pre-activity dosing — Sometimes used for recovery-focused peptides. Timing around workouts is a common protocol pattern, though optimal timing varies by compound.

How to Use the Half-Life Visualizer

ClearDosage includes a Half-Life Visualizer that lets you:

• See how concentration decays over time for any compound in the library
• Compare multiple peptides on one chart to understand stack overlap
• Visualize steady-state accumulation across repeated doses
• Adjust dose amount to see how it shifts the decay curve

Open the Library, navigate to a compound, and tap View in Half-Life Visualizer to pre-load that compound's data.

Common Questions

Does a longer half-life mean stronger effects? Not directly. Half-life affects duration, not potency. A compound with a short half-life isn't weaker — it just clears faster.

Should I time injections around food or activity? Timing protocols vary by compound and goal. This is a topic to review with a qualified clinician for any personal protocol.

Why do some sources list very different half-life values? Half-life data for research peptides often comes from limited studies with small samples, different routes of administration, or different analytical methods. Values in the literature should be treated as approximate references.

Use the Half-Life Visualizer in ClearDosage to model your specific dosing schedule and see how different intervals affect coverage over time.